China Money Network
Login
Join

Oceanpine Capital Leads $80M Series B Round In China-US Biotech Firm Ansun BioPharma

  • October 15, 2019 — 14:02 CST

This Data Is Locked!

This area is available only to Subscribers.

Ansun BioPharma, a China-US based clinical stage biopharmaceutical company, has raised US$80 million in a series B round of financing led by Chinese investment management... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: